Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.

Source:http://linkedlifedata.com/resource/pubmed/id/18821707

Download in:

View as

General Info

PMID
18821707